Sucampo Announces New Data on AMITIZA and Opioid-Induced Constipation Published Online in Pain Medicine Journal

[GlobeNewswire] – BETHESDA, Md. — Sucampo Pharmaceuticals, Inc. (Sucampo) , a global biopharmaceutical company, announced that its recent study, A Randomized Study of Lubiprostone for Opioid-Induced Constipation … more

View todays social media effects on SCMP

View the latest stocks trending across Twitter. Click to view dashboard

See who Sucampo is hiring next, click here to view